
Aytu BioPharma, Inc.
NASDAQ:AYTU
1.21 (USD) • At close May 8, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Aytu BioPharma, Inc. |
Symbool | AYTU |
Munteenheid | USD |
Prijs | 1.213 |
Beurswaarde | 7,484,149 |
Dividendpercentage | 0% |
52-weken bereik | 0.95 - 3.45 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Joshua R. Disbrow |
Website | https://aytubio.com |
An error occurred while fetching data.
Over Aytu BioPharma, Inc.
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)